Rebif is a brand name of Interferon BETA-1A, a prescription medicine. The FDA NDC Directory lists 2 Rebif products in 2 strengths and forms.

Serono Inc holds the FDA application for Rebif (BLA103780, approved March 7, 2002).

Is there a generic or store brand of Rebif?

Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Rebif product. Ask your pharmacist whether one is right for you.

Rebif (Interferon BETA-1A): maker, FDA approval and generic versions

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Rebif?: Rebif is a brand name of Interferon BETA-1A, a prescription medicine. The FDA NDC Directory lists 2 Rebif products in 2 strengths and forms.
Who makes Rebif?: Serono Inc holds the FDA application for Rebif (BLA103780, approved March 7, 2002).
Is there a generic or store brand of Rebif?: Yes. The FDA NDC Directory lists 2 other products with the same active ingredients, strength and form as a Rebif product. Ask your pharmacist whether one is right for you.
Has Rebif been recalled?: No recall linked to Rebif products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Rebif is

Each Rebif product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Interferon BETA-1A · prescription medicine

Strength and form	Product names	Same medicine, other names	Label
interferon BETA-1A 22 ug/0.5 mL injection, solution (subcutaneous)	Rebif	1 product, 1 company	DailyMed
interferon BETA-1A 44 ug/0.5 mL injection, solution (subcutaneous)	Rebif	1 product, 1 company	DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Interferon BETA-1A →

FDA approval

BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.

FDA applications of Rebif products (Drugs@FDA)
Application	Holder	First approved	Products
BLA103780	Serono Inc	March 7, 2002	2

Companies that list Rebif

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Rebif products.

EMD Serono, Inc.2 products

Recalls

No recall linked to Rebif products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers

Rebif